Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in SPYRE THERAPEUTICS INC
DRIEHAUS CAPITAL MANAGEMENT LLC holds 2.9M shares of SYRE (SPYRE THERAPEUTICS INC), worth $94.4M as of 2025-Q4. The position was increased (++39.9% shares). SYRE represents 0.6% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$94.4M
Current Shares
2.9M
Total Value Change
+$78.3M
Total Shares Change
+2.2M
Other major holders of SYRE: FMR LLC, BlackRock, Inc.
Increased |
| 2.9M |
+39.9% |
| $94.4M |
| 0.6% |
| $31.88 |
56 |
| 2025-Q3 | Decreased | 2.1M | -1.2% | $34.5M | 0.2% | $16.36 | 0 |
| 2025-Q2 | Decreased | 2.1M | -23.3% | $31.2M | 0.2% | $15.22 | 0 |
| 2025-Q1 | Decreased | 2.7M | -3.1% | $43.8M | 0.4% | $17.94 | 0 |
| 2024-Q4 | Increased | 2.8M | +308.1% | $65.3M | 0.5% | $22.54 | 67 |
| 2024-Q3 | Unchanged | 687,080 | 0.0% | $20.2M | 0.2% | $28.49 | 0 |
| 2024-Q2 | Unchanged | 687,080 | 0.0% | $16.2M | 0.2% | $23.51 | 0 |